Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC. (18th February 2022)

• Record Type: Journal Article
• Authors: Hasselblatt, Martin; Thomas, Christian; Federico, Aniello; Bens, Susanne; Hellström, Mats; Casar‐Borota, Olivera; Kordes, Uwe; Neumann, Julia E.; Dottermusch, Matthias; Rodriguez, Fausto J.; Lo, Andrea C.; Cheng, Sylvia; Hendson, Glenda; Hukin, Juliette; Hartmann, Christian; Koch, Arend; Capper, David; Siebert, Reiner; Paulus, Werner; Nemes, Karolina; Johann, Pascal D.; Frühwald, Michael C.; Kool, Marcel
• Is Part Of: Neuropathology & applied neurobiology. Volume 48:Number 4(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-02-18
• Subjects: atypical teratoid/rhabdoid tumour -- central nervous system low‐grade diffusely infiltrative tumour with INI1 deficiency -- DNA methylation profiling -- neuropathology; Nervous system -- Diseases -- Pathology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/nan.12797
• Languages: English
• ISSNs: 0305-1846

Abstract

Abstract : Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant, is a histopathological distinct low‐grade lesion encountered in older children and young adults that shows epigenetic similarity with ATRT‐MYC and has the potential for malignant progression.